To address the problem, healthcare policymakers are considering the creation of obstetrical levels of caution at hospitals, very much like what is in place for newborns. For the past 40 years, hospitals have standardized the care of newborns into 'levels,' with Level I offering simple neonatal care to mom and child, up to Level Level or III IV – neonatal intensive care devices, or NICUs, for newborns recovering from serious disease or who had been born premature extremely, Gregory said. Our study seeks to recognize what would constitute an even I, or low-risk obstetrical device, and what would be required for a known level IV designation for high-risk pregnancies.Dr Hayball, Dr Michael Brown and Dr Paul Howley were recently successful in winning a three-year Australian Research Council Linkage Project grant with sector partner Virax Holdings Limited by develop the fowlpox virus vector technology. A biotechnology firm located in Melbourne, Virax is normally developing a few of the world’s most promising immune-based therapies for HIV/AIDS, various other infectious diseases, autoimmune diseases and tumor. Related StoriesCamels in Kenya contaminated by MERS virus, brand-new study findsUC Irvine Health researchers develop one-step test to identify HCV infectionsJohns Hopkins doctors desire people to obtain vaccinated against influenza virus’The fowlpox virus can be an ideal vaccine vector since it does not trigger disease when found in humans,’ Dr Hayball said.